MedTrace Logo

A Study to Assess the Safety, Tolerability and Pharmacokinetics of PAC-14028 Cream in Healthy Male Subjects

NCT02309008 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2016-04-22

No results posted yet for this study

Summary

The purpose of this study is to investigate the safety/tolerability and pharmacokinetics of PAC-14028 cream after transdermal administration in healthy male volunteers.

Conditions

  • Healthy

Interventions

DRUG

PAC-14028

Participants will receive PAC-14028 cream applied topically once a day for 9 days

OTHER

Vehicle

Participants will receive vehicle cream applied topically once a day for 9 days

Sponsors & Collaborators

  • Seoul National University Hospital

    collaborator OTHER

  • Amorepacific Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2016-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02309008 on ClinicalTrials.gov